Literature DB >> 21469124

IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans.

Stefanie Eyerich1, Jeanette Wagener, Vera Wenzel, Claudia Scarponi, Davide Pennino, Cristina Albanesi, Martin Schaller, Heidrun Behrendt, Johannes Ring, Carsten B Schmidt-Weber, Andrea Cavani, Martin Mempel, Claudia Traidl-Hoffmann, Kilian Eyerich.   

Abstract

T cells exercise their full impact on target cells through a combination of secreted cytokines. The recently described T helper cell subset Th22 is characterized by a combinatorial secretion of IL-22 and TNF-α. Here, we demonstrate that IL-22 increases the TNF-α-dependent induction and secretion of several immune-modulatory molecules such as initial complement factors C1r and C1s, antimicrobial peptides S100A7 and HBD-2 (human β defensin 2), and antimicrobial chemokines CXCL-9/-10/-11 in primary human keratinocytes. The synergism of IL-22 and TNF-α is transmitted intracellularly by MAP kinases and downstream by transcription factors of the AP-1 family. The induction of innate immunity is relevant in an in vitro infection model, where keratinocytes stimulated with Th22 supernatants or recombinant IL-22 plus TNF-α effectively inhibit the growth of Candida albicans and maintain survival of epithelia. Accordingly, the combinatorial stimulation of keratinocytes with IL-22 and TNF-α most efficiently conserves the integrity of the epidermal barrier in a three-dimensional skin infection model as compared with IFN-γ, IL-17, IL-22 or TNF-α alone. In summary, we demonstrate that IL-22 and TNF-α represent a potent, synergistic cytokine combination for cutaneous immunity.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21469124     DOI: 10.1002/eji.201041197

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  52 in total

Review 1.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

3.  DCs: a dual bridge to protective immunity.

Authors:  Federica Sallusto
Journal:  Nat Immunol       Date:  2013-09       Impact factor: 25.606

Review 4.  Interplay between Candida albicans and the antimicrobial peptide armory.

Authors:  Marc Swidergall; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2014-06-20

Review 5.  Mechanisms of interleukin-22's beneficial effects in acute pancreatitis.

Authors:  Chongmin Huan; Daniel Kim; Peiqi Ou; Antonio Alfonso; Albert Stanek
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 6.  The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.

Authors:  Casey T Weaver; Charles O Elson; Lynette A Fouser; Jay K Kolls
Journal:  Annu Rev Pathol       Date:  2012-11-15       Impact factor: 23.472

Review 7.  C-type lectin receptors in the control of T helper cell differentiation.

Authors:  Teunis B H Geijtenbeek; Sonja I Gringhuis
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

Review 8.  Interleukin-22: a likely target for treatment of autoimmune diseases.

Authors:  Xuyan Yang; Song Guo Zheng
Journal:  Autoimmun Rev       Date:  2014-01-10       Impact factor: 9.754

9.  Limited Role of Mincle in the Host Defense against Infection with Cryptococcus deneoformans.

Authors:  Yuki Sato; Ko Sato; Hideki Yamamoto; Jun Kasamatsu; Tomomitsu Miyasaka; Daiki Tanno; Anna Miyahara; Takafumi Kagesawa; Akiho Oniyama; Kotone Kawamura; Rin Yokoyama; Yuki Kitai; Aya Umeki; Shigenari Ishizuka; Kazuki Takano; Ryuhei Shiroma; Nana Nakahata; Kaori Kawakami; Emi Kanno; Hiromasa Tanno; Sho Yamasaki; Hiromitsu Hara; Keiko Ishii; Kazuyoshi Kawakami
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 10.  IL-22 in tissue-protective therapy.

Authors:  Heiko Mühl; Patrick Scheiermann; Malte Bachmann; Lorena Härdle; Anika Heinrichs; Josef Pfeilschifter
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.